Tvardi Therapeutics announces June 9, 2026 annual meeting; sets proposal deadlines

Tvardi Therapeutics, Inc.

Annual meeting of stockholders scheduled for June 9, 2026.
Rule 14a-8 stockholder proposals for proxy inclusion must be received by March 16, 2026.
Advance notice for director nominations and other business under bylaws due March 16, 2026.
Universal proxy rule (Rule 14a-19) notices for director nominees due April 10, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.